Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19 studies found for:    Open Studies | "Rhinitis, Allergic, Seasonal"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Rhinitis, Allergic, Seasonal"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Observational Study With PASCALLERG ® in Patients With Hay Fever
Condition: Hay Fever
2 Recruiting Effectiveness of Bifidobacteria in Children Affected by Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Bifidobacteria;   Drug: placebo
3 Recruiting Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)
Condition: Seasonal Allergic Rhinitis (SAR)
Interventions: Drug: GSP 301 NS;   Drug: GOM-NS;   Drug: GMM-2 NS;   Drug: GSP 301 placebo NS
4 Unknown  Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: montelukast;   Drug: cetirizine;   Drug: montelukast and cetirizine;   Drug: placebo
5 Recruiting Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)
Condition: Rhinitis, Allergic, Seasonal
Interventions: Biological: MK-3641;   Biological: Placebo;   Drug: Self-injectable epinephrine;   Drug: Albuterol/Salbutamol;   Drug: Loratadine;   Drug: Olopatadine;   Drug: Mometasone furoate monohydrate
6 Unknown  Optimal Concentration of Dermatophagoides Pteronyssinus (Dp) Allergen Extract for Skin Prick Test (SPT) of Thai Population
Conditions: Rhinitis, Allergic, Perennial;   Rhinitis, Allergic, Seasonal;   Skin Prick Test
7 Recruiting Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis
Condition: Hay Fever
Interventions: Biological: Placebo solution;   Biological: gpASIT+TM
8 Not yet recruiting Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
Conditions: Lung Transplant;   Lung Resection;   Lung Cancer;   Asthma;   Cystic Fibrosis;   Chronic Obstructive Pulmonary Disease;   Emphysema;   Mesothelioma;   Asbestosis;   Pulmonary Embolism;   Interstitial Lung Disease;   Pulmonary Fibrosis;   Bronchiectasis;   Seasonal Allergies;   Cold Virus;   Lung Infection;   Pulmonary Hypertension;   Pulmonary Dysplasia;   Obstructive Sleep Apnea
Interventions: Drug: HP 3He;   Drug: HP 129Xe;   Drug: PFP;   Drug: SF6;   Device: 129Xe Small and Large Human Lung Coil;   Device: 3He Human Lung Coil;   Device: PFP and SF6 Human Lung Coil
9 Unknown  Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Azelastine hydrochloride and Fluticasone propionate;   Drug: Dymista™;   Other: Placebo
10 Unknown  Effect of the Nasal Provocation on the Breathing Style
Conditions: Birch Pollen Allergy;   Healthy Control Subjects
Intervention: Biological: 1. session birch pollen nasal exposure 2. session xylometazoline nasal exposure
11 Unknown  Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy
Conditions: Birch Pollen Related Apple Allergy;   Birch Pollen Allergy
Interventions: Drug: rMal d 1;   Drug: rBet v 1;   Other: placebo drops
12 Unknown  Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Other: Grass pollen sublingual immunotherapy tablet;   Drug: Control
13 Not yet recruiting Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy
Conditions: Rhinitis;   Rhinoconjunctivitis
Interventions: Biological: MG56 Mannosylated 5.000 subcutaneous;   Biological: MG56 Mannosylated 10.000 subcutaneous;   Biological: MG56 Mannosylated 30.000 subcutaneous;   Biological: MG56 Mannosylated 50.000 subcutaneous;   Biological: MG56 Mannosylated 5.000 sublingual;   Biological: MG56 Mannosylated 10.000 sublingual;   Biological: MG56 Mannosylated 30.000 sublingual;   Biological: MG56 Mannosylated 50.000 sublingual;   Biological: Subcutaneous placebo;   Biological: Sublingual placebo
14 Recruiting Evaluating Factors Involved in Dymista's Superior Clinical Efficacy to Fluticasone Propionate in the Treatment of Seasonal Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Drug: Placebo;   Drug: Fluticasone propionate;   Drug: Fluticasone/Azelastine nasal spray;   Procedure: Nasal Allergen Challenge
15 Not yet recruiting A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
Conditions: Allergic Rhinitis;   Allergic Conjunctivitis
Interventions: Biological: modified allergen extract;   Biological: Placebo
16 Not yet recruiting Efficacy and Safety of Sublingual Immunotherapy (SLIT)
Condition: Allergic Rhinitis
Interventions: Biological: sublingual immunotherapy with allergen extract;   Biological: sublingual immunotherapy with placebo
17 Recruiting Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen
Conditions: Allergic Rhinitis;   Asthma;   Latent Tuberculosis
Interventions: Other: TLR Agonist;   Other: Tuberculin nasal challenge;   Other: Timothy Grass Pollen
18 Recruiting Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response
Condition: Hypersensitivity
Interventions: Biological: BM32;   Biological: Placebo
19 Unknown  Analysis of Immunological Reactions to Foods in Birch Pollen-Allergic Patients
Conditions: Allergic Rhinitis;   Food Allergy

Indicates status has not been verified in more than two years